International prospective observational cohort study of Zika in infants and pregnancy (ZIP study): study protocol

Jill F Lebov, Juan F Arias, Angel Balmaseda, William Britt, José F Cordero, Luiz Augusto Galvão, Ana Lucía Garces, K Michael Hambidge, Eva Harris, Albert Ko, Nancy Krebs, Ernesto T A Marques, Alexander M Martinez, Elizabeth McClure, Democrito B Miranda-Filho, Maria Elisabeth Lopes Moreira, Marisa M Mussi-Pinhata, Theresa J Ochoa, Jorge E Osorio, Deolinda M F Scalabrin, Stacey Schultz-Cherry, George R Seage 3rd, Kristen Stolka, César Augusto Ugarte-Gil, Carmen Milagros Velez Vega, Michael Welton, Ricardo Ximenes, Carmen Zorrilla, Jill F Lebov, Juan F Arias, Angel Balmaseda, William Britt, José F Cordero, Luiz Augusto Galvão, Ana Lucía Garces, K Michael Hambidge, Eva Harris, Albert Ko, Nancy Krebs, Ernesto T A Marques, Alexander M Martinez, Elizabeth McClure, Democrito B Miranda-Filho, Maria Elisabeth Lopes Moreira, Marisa M Mussi-Pinhata, Theresa J Ochoa, Jorge E Osorio, Deolinda M F Scalabrin, Stacey Schultz-Cherry, George R Seage 3rd, Kristen Stolka, César Augusto Ugarte-Gil, Carmen Milagros Velez Vega, Michael Welton, Ricardo Ximenes, Carmen Zorrilla

Abstract

Background: Until recently, Zika virus (ZIKV) infections were considered mild and self-limiting. Since 2015, they have been associated with an increase in microcephaly and other birth defects in newborns. While this association has been observed in case reports and epidemiological studies, the nature and extent of the relationship between ZIKV and adverse pregnancy and pediatric health outcomes is not well understood. With the unique opportunity to prospectively explore the full spectrum of issues related to ZIKV exposure during pregnancy, we undertook a multi-country, prospective cohort study to evaluate the association between ZIKV and pregnancy, neonatal, and infant outcomes.

Methods: At research sites in ZIKV endemic regions of Brazil (4 sites), Colombia, Guatemala, Nicaragua, Puerto Rico (2 sites), and Peru, up to 10,000 pregnant women will be recruited and consented in the first and early second trimesters of pregnancy and then followed through delivery up to 6 weeks post-partum; their infants will be followed until at least 1 year of age. Pregnant women with symptomatic ZIKV infection confirmed by presence of ZIKV RNA and/or IgM for ZIKV will also be enrolled, regardless of gestational age. Participants will be tested monthly for ZIKV infection; additional demographic, physical, laboratory and environmental data will be collected to assess the potential interaction of these variables with ZIKV infection. Delivery outcomes and detailed infant assessments, including physical and neurological outcomes, will be obtained.

Discussion: With the emergence of ZIKV in the Americas and its association with adverse pregnancy outcomes in this region, a much better understanding of the spectrum of clinical outcomes associated with exposure to ZIKV during pregnancy is needed. This cohort study will provide information about maternal, fetal, and infant outcomes related to ZIKV infection, including congenital ZIKV syndrome, and manifestations that are not detectable at birth but may appear during the first year of life. In addition, the flexibility of the study design has provided an opportunity to modify study parameters in real time to provide rigorous research data to answer the most critical questions about the impact of congenital ZIKV exposure.

Trial registration: NCT02856984 . Registered August 5, 2016. Retrospectively registered.

Keywords: Latin America; Microcephaly; Pregnancy; Zika virus.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Hurtado-Villa Paula, Puerto Angie K., Victoria Salomé, Gracia Gloria, Guasmayán Lesly, Arce Patricia, Álvarez Gilberto, Blandón Esperanza, Rengifo Nubia, Holguín Jorge A., Durán Alexander, Zarante Ignacio. Raised Frequency of Microcephaly Related to Zika Virus Infection in Two Birth Defects Surveillance Systems in Bogotá and Cali, Colombia. The Pediatric Infectious Disease Journal. 2017;36(10):1017–1019. doi: 10.1097/INF.0000000000001670.
    1. Moura da Silva AA, Ganz JS, Sousa PD, Doriqui MJ, Ribeiro MR, Branco MD, et al. Early Growth and Neurologic Outcomes of Infants with Probable Congenital Zika Virus Syndrome. Emerg Infect Dis. 2016;22(11):1953–1956. doi: 10.3201/eid2211.160956.
    1. Petersen LR, et al. Zika Virus. N Engl J Med. 2016;374(16):1552–1563. doi: 10.1056/NEJMra1602113.
    1. Paixao ES, et al. History, epidemiology, and clinical manifestations of Zika: a systematic review. Am J Public Health. 2016;106(4):606–612. doi: 10.2105/AJPH.2016.303112.
    1. Fauci AS, Morens DM. Zika virus in the Americas--yet another arbovirus threat. N Engl J Med. 2016;374(7):601–604. doi: 10.1056/NEJMp1600297.
    1. Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009;15(9):1347–1350. doi: 10.3201/eid1509.090442.
    1. Weaver SC, et al. Zika virus: history, emergence, biology, and prospects for control. Antivir Res. 2016;130:69–80. doi: 10.1016/j.antiviral.2016.03.010.
    1. Mallet HP, Vial AL, Musso D. Bilan de l’épidémie à virus Zika survenue en Polynésie française entre octobre 2013 et mars 2014. De la description de l’épidémie aux connaissances acquises après l’évènement. Bull Epidemiol Hebd. 2016;20(21):367–73.
    1. Duffy MR, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360(24):2536–2543. doi: 10.1056/NEJMoa0805715.
    1. Cao-Lormeau V-M, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531–39. doi: 10.1016/S0140-6736(16)00562-6.
    1. Brasil P, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med. 2016;375(24):2321–34. doi: 10.1056/NEJMoa1602412.
    1. Kleber de Oliveira W, et al. Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(9):242–247. doi: 10.15585/mmwr.mm6509e2.
    1. de Araújo TVB, et al. Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study. Lancet Infect Dis. 2018;18(3):328–36. doi: 10.1016/S1473-3099(17)30727-2.
    1. Rasmussen SA, et al. Zika virus and birth defects — reviewing the evidence for causality. N Engl J Med. 2016;374(20):1981–1987. doi: 10.1056/NEJMsr1604338.
    1. Besnard M, Eyrolle-Guignot D, Guillemette-Artur P, Lastère S, Bost-Bezeaud F, Marcelis L, Abadie V, Garel C, Moutard M, Jouannic J, Rozenberg F, Leparc-Goffart I, Mallet H. Congenital cerebral malformations and dysfunction in fetuses and newborns following the 2013 to 2014 Zika virus epidemic in French Polynesia. Euro Surveill. 2016;21(13). 10.2807/1560-7917.ES.2016.21.13.30181.
    1. Honein MA, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. Jama. 2017;317(1):59–68. doi: 10.1001/jama.2016.19006.
    1. Cuevas EL, et al. Preliminary report of microcephaly potentially associated with Zika virus infection during pregnancy - Colombia, January-November 2016. MMWR Morb Mortal Wkly Rep. 2016;65(49):1409–1413. doi: 10.15585/mmwr.mm6549e1.
    1. Hoen B, et al. Pregnancy outcomes after ZIKV infection in French territories in the Americas. N Engl J Med. 2018;378(11):985–994. doi: 10.1056/NEJMoa1709481.
    1. Reynolds MR, et al. Vital signs: update on Zika virus-associated birth defects and evaluation of all U.S. infants with congenital Zika virus exposure - U.S. Zika pregnancy registry, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(13):366–373. doi: 10.15585/mmwr.mm6613e1.
    1. Costa F, et al. Emergence of congenital Zika syndrome: viewpoint from the front lines. Ann Intern Med. 2016;164(10):689–691. doi: 10.7326/M16-0332.
    1. Moore CA, et al. Characterizing the pattern of anomalies in congenital zika syndrome for pediatric clinicians. JAMA Pediatr. 2017;171(3):288–295. doi: 10.1001/jamapediatrics.2016.3982.
    1. Del Campo M, et al. The phenotypic spectrum of congenital Zika syndrome. Am J Med Genet A. 2017;173(4):841–857. doi: 10.1002/ajmg.a.38170.
    1. Microcephaly Epidemic Research Group Microcephaly in infants, Pernambuco state, Brazil, 2015. Emerg Infect Dis J. 2016;22(6):1090. doi: 10.3201/eid2206.160062.
    1. de Paula Freitas Bruno, de Oliveira Dias João Rafael, Prazeres Juliana, Sacramento Gielson Almeida, Ko Albert Icksang, Maia Maurício, Belfort Rubens. Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil. JAMA Ophthalmology. 2016;134(5):529. doi: 10.1001/jamaophthalmol.2016.0267.
    1. Zin AA, et al. Screening criteria for ophthalmic manifestations of congenital Zika virus infection. JAMA Pediatr. 2017;171(9):847–854. doi: 10.1001/jamapediatrics.2017.1474.
    1. Leal MC, et al. Hearing loss in infants with microcephaly and evidence of congenital Zika virus infection - Brazil, November 2015-may 2016. MMWR Morb Mortal Wkly Rep. 2016;65(34):917–919. doi: 10.15585/mmwr.mm6534e3.
    1. Guillemette-Artur P, et al. Prenatal brain MRI of fetuses with Zika virus infection. Pediatr Radiol. 2016;46(7):1032–1039. doi: 10.1007/s00247-016-3619-6.
    1. de Fatima Vasco Aragao M, et al. Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study. BMJ. 2016;353:i1901. doi: 10.1136/bmj.i1901.
    1. van der Linden V, et al. Description of 13 infants born during October 2015-January 2016 with congenital Zika virus infection without microcephaly at birth - Brazil. MMWR Morb Mortal Wkly Rep. 2016;65(47):1343–1348. doi: 10.15585/mmwr.mm6547e2.
    1. Cerbino-Neto J, et al. Clinical manifestations of Zika virus infection, Rio de Janeiro, Brazil, 2015. Emerg Infect Dis. 2016;22(7):1318–1320. doi: 10.3201/eid2207.160375.
    1. Sarno M, et al. Zika virus infection and stillbirths: a case of Hydrops Fetalis, Hydranencephaly and fetal demise. PLoS Negl Trop Dis. 2016;10(2):e0004517. doi: 10.1371/journal.pntd.0004517.
    1. Oduyebo T, et al. Update: interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible Zika virus exposure - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(5):122–127. doi: 10.15585/mmwr.mm6505e2.
    1. Harris PA, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa